{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T19:53:15Z","timestamp":1648669995839},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1016\/j.mehy.2004.02.012","type":"journal-article","created":{"date-parts":[[2004,4,14]],"date-time":"2004-04-14T09:27:06Z","timestamp":1081934826000},"page":"26-30","source":"Crossref","is-referenced-by-count":3,"title":["A novel approach to the psychopharmacologic treatment of insomnia in depression"],"prefix":"10.1016","volume":"63","author":[{"given":"Aelred","family":"Boyle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mehy.2004.02.012_BIB1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1067\/mcp.2002.129318","article-title":"Benzodiazepines and the risk of urinary incontinence in frail older persons living in the community","volume":"72","author":"Landi","year":"2002","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.mehy.2004.02.012_BIB2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/070674370204700202","article-title":"\u201cCade's disease\u201d and beyond: misdiagnosis, anti-depressant use, and a proposed definition for bipolar spectrum disorder","volume":"47","author":"Ghaemi","year":"2002","journal-title":"Can J Psychiatry"},{"issue":"1","key":"10.1016\/j.mehy.2004.02.012_BIB3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2007-1014476","article-title":"Sensitization and kindling perspectives for the course of affective illness: toward a new treatment with the anti-convulsant carbamazepine","volume":"23","author":"Post","year":"1990","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.mehy.2004.02.012_BIB4","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/2141020a0","article-title":"Development of epileptic seizures through brain stimulation at low intensity","volume":"214","author":"Goddard","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.mehy.2004.02.012_BIB5","unstructured":"The Practitioner 1907;1:166, as quoted in Squires' Companion to British Pharmacopoeia 1908, as quoted in Cade, op cit"},{"issue":"1","key":"10.1016\/j.mehy.2004.02.012_BIB6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-1211(98)00108-9","article-title":"Progress report on new anti-epileptic drugs: a summary of the fourth Eilat conference (EILAT IV)","volume":"34","author":"Bialer","year":"1999","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.mehy.2004.02.012_BIB7","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1345\/aph.1A011","article-title":"Gabapentin treatment for bipolar disorders","volume":"35","author":"Maidment","year":"2001","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.mehy.2004.02.012_BIB8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1176\/ajp.157.1.151","article-title":"Gabapentin treatment for insomnia associated with alcohol dependence","volume":"157","author":"Karam-Hage","year":"2000","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.mehy.2004.02.012_BIB9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.3928\/0048-5713-20021201-12","article-title":"Mood-stabilizing properties of Lamotrigine: a review of data from controlled clinical trials","volume":"32","author":"Leadbetter","year":"2002","journal-title":"Psychiat Ann"},{"key":"10.1016\/j.mehy.2004.02.012_BIB10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0014-2999(95)00436-O","article-title":"The novel anti-epileptic drug levetiracetam (ucb LO59) appears to act via a specific binding site in CNS membranes","volume":"286","author":"Noyer","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.mehy.2004.02.012_BIB11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","article-title":"Selective blockade of N-type calcium channels by levetiracetam","volume":"43","author":"Lukyanetz","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.mehy.2004.02.012_BIB12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","article-title":"Levetiracetam inhibits the high-voltage-activated Ca2+ current in pyramidal neurones of rat hippocampal slices","volume":"306","author":"Niespodziany","year":"2001","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.mehy.2004.02.012_BIB13","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/sj.bjp.0704766","article-title":"The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents","volume":"136","author":"Rigo","year":"2002","journal-title":"Brit J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2004.02.012_BIB14","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s002130050117","article-title":"The place of anti-convulsant therapy in bipolar illness","volume":"128","author":"Post","year":"1996","journal-title":"Psychopharmacology"},{"issue":"2","key":"10.1016\/j.mehy.2004.02.012_BIB15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0922-4106(94)90089-2","article-title":"Tiagabine, SK & F 89976-A, CI-966, and NNC-711 are selective for the cloned GABA transporter GAT-1","volume":"269","author":"Borden","year":"1994","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2004.02.012_BIB16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0197-4580(00)00232-3","article-title":"The GABA uptake inhibitor tiagabine promotes slow wave sleep in normal elderly subjects","volume":"22","author":"Mathias","year":"2001","journal-title":"Neurobiol Aging"},{"issue":"6","key":"10.1016\/j.mehy.2004.02.012_BIB17","first-page":"599","article-title":"Review of the use of topiramate for treatment of bipolar disorders","volume":"22","author":"Suppes","year":"2002","journal-title":"J Clin Psychiatry"},{"issue":"10","key":"10.1016\/j.mehy.2004.02.012_BIB18","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00023210-200216100-00003","article-title":"Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy","volume":"16","author":"Loscher","year":"2002","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.mehy.2004.02.012_BIB19","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1432-1033.1995.794_a.x","article-title":"Phylogenetic conservation of 4-aminobutyric acid (GABA) transporter isoforms. Cloning and pharmacological characterization of a GABA\/\u03b2-alanine transporter from Torpedo","volume":"234","author":"Guimbal","year":"1995","journal-title":"Eur J Biochem"},{"issue":"Suppl 3","key":"10.1016\/j.mehy.2004.02.012_BIB20","first-page":"7","article-title":"Magnetic Resonance Spectroscopy studies of GABA in neuropsychiatric disorders","volume":"64","author":"Chang","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2004.02.012_BIB21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0165-0327(02)00332-4","article-title":"The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases","volume":"73","author":"Judd","year":"2003","journal-title":"J Affect Disorders"},{"key":"10.1016\/j.mehy.2004.02.012_BIB22","unstructured":"Cade, John FJ. Lithium salts in the treatment of psychotic excitement. Med J Australia 1949;2:349\u2013352. Reprinted in Mitchell PB, Hadzi-Pavlovic D. Bull World Health Organ 2000;78(4):518\u2013520"},{"issue":"5","key":"10.1016\/j.mehy.2004.02.012_BIB23","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/archpsyc.1979.01780050065007","article-title":"Rapid cycling in manic-depressives induced by tricyclic anti-depressants","volume":"36","author":"Wehr","year":"1979","journal-title":"Arch Gen Psychiat"},{"issue":"10","key":"10.1016\/j.mehy.2004.02.012_BIB24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4088\/JCP.v61n1013","article-title":"Diagnosing bipolar disorder and the effect of anti-depressants: a naturalistic study","volume":"61","author":"Ghaemi","year":"2000","journal-title":"J Clin Psychiatry"},{"issue":"8 spec no","key":"10.1016\/j.mehy.2004.02.012_BIB25","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/archpsyc.1979.01780080009002","article-title":"Major affective disorder as a recurrent illness: a critical review","volume":"36","author":"Zis","year":"1979","journal-title":"Arch Gen Psych"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704001197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987704001197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T02:26:11Z","timestamp":1550111171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987704001197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["S0306987704001197"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2004.02.012","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}